HealthDay News — For patients with lentigo maligna (LM) in-situ melanoma, topical imiquimod has a pathological complete regression (pCR) rate of 37%, according to a study published online October 6 in ...

The use of topical imiquimod was found to effectively promote regression of precancerous cervical lesions, according to a phase II randomized controlled trial. In a per-protocol population of women ...

Please provide your email address to receive an email when new articles are posted on . Imiquimod treatment for 16 weeks exhibited a 90% tumor clearance rate in persistent MMIS at margins of resection ...

Although all authors completed the disclosure declaration, the following author(s) indicated a financial or other interest that is relevant to the subject matter under consideration in this article.

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Five years after treatment, results showed a freedom ...

Our analysis of currently available data regarding imiquimod (Aldara) is that it can likely be used in renal transplant recipients without incurring a probable risk of acute rejection. However, ...

A cream currently used to treat skin cancers and warts could hold the answer to stopping scar formation after injuries or surgery, suggests early-stage research from the University of Pennsylvania.